Loss of caveolin and heme oxygenase expression in severe pulmonary hypertension

Chest

Volumn 129, Issue 3, 2006, Pages 696-705

  Achcar, Rosane O D ^d   Demura, Yoshiki ^d   Rai, Pradeep R ^a   Taraseviciene Stewart, Laima ^d   Kasper, Michael ^b   Voelkel, Norbert F ^c   Cool, Carlyne D ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Division of Pulmonary Sciences and Critical Care Medicine   (United States)

^d NONE

Author keywords

Caveolin; Heme oxygenase 1; Pulmonary hypertension

Indexed keywords

CAVEOLIN; CAVEOLIN 1; CAVEOLIN 2; HEME OXYGENASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIOLE; ARTICLE; CAVEOLA; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOCALIZATION; LUNG; LUNG ALVEOLUS CELL; LUNG ENDOTHELIUM; LUNG FIBROBLAST; MALE; NONHUMAN; PLEXIFORM LESION; PRECAPILLARY ARTERIOLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE; VASCULAR LESION; WESTERN BLOTTING;

EID: 33645124085     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.3.696     Document Type: Article

References (50)

1. Shaul PW, RG Anderson. Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998; 275(5. pt 1):L843-L851
2. Couet J, Belanger MM, Roussel E, et al. Cell biology of caveolae and caveolin. Adv Drug Deliv Rev 2001; 49:223-235
3. Razani B, Schlegel A, Liu J, et al. Caveolin, a putative tumor suppressor gene. Biochem Soc Trans 2001; 29:494-499
4. Rothberg KG, Heuser JE, Donzell WC, et al. Caveolin, a protein component of caveolae membranes coats. Cell 1992; 68:673-682
5. Scherer PE, Okamoto T, Chun M, et al. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci U S A 1996; 93:131-135
6. Tang Z, Scherer PE, Okamoto T, et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996; 271:2255-2261
7. Li S, Couet J, Lisanti SC. Src tyrosine kinases, Ga subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin: caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 1996; 271:29182-29190
8. Couet J, Okamoto T, Ikezu T, et al. Identification of peptide and protein ligands for the caveolin-scaffolding domain: implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997; 272:6525-6533
9. Okamoto T, Schleger A, Scherer PE, et al. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 1998; 273:5419-5422
10. Simons K, Toomre. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2001; 1:31-39
11. Galbiati F, Razani B, Lisanti MP. Emerging themes in lipid rafts and caveolae. Cell 2001; 106:403-411
12. Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci U S A 2001; 92:1381-1385
13. Engelman JA, Wykoff CC, Yasuhara S, et al. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 1997; 272:16374-16381
14. Lee SW, Oh P, Reimer CL, et al. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998; 16:1391-1397
15. Razani B, Engelman JA, Wang XB, et al. Caveolin-1 null mice are viable, but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001; 276:38121-38138
16. Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001; 293:2449-2452
17. Razani B, Wang XB, Engelman JA, et al. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 2002; 22:2329-2344
18. Tuder RM, Groves BM, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol 1994; 144:275-285
19. Cool CD, Kennedy D, Voelkel NF, et al. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997; 28:434-442
20. Cool CD, Stewart JS, Werahera P, et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol 1999; 155:411-419
21. Tuder RM, Radisavljevic Z, Shroyer KR, et al. Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension. Am J Respir Crit Care Med 1998; 158:1999-2001
22. Geraci MW, Moore M, Gesell T, et al. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 2001; 88:555-562
23. Taraseviciene-Stewart L, Kasahara Y, Alger L, et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependant pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001; 15:427-438
24. Mathew R, Huang J, Shah M, et al. Disruption of endothelial - cell caveolin-1 alpha/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation 2004; 110:1499-1506
25. Jung NH, Kim HP, Kim BR, et al. Evidence for heme oxygenase-1 association with caveolin-1 and 2 in mouse mesangial cells. IUBMB Life 2003; 55:525-532
26. Kim HP, Wang X, Galbiati F, et al. Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J 2004; 18:1080-1089
27. Christou H, Monta T, Hsieh C-M, et al. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 2000; 86:1224-1229
28. Sehested M, JK Hou. Factor VIII-related antigen as an endothelial cell marker in benign and malignant diseases. Virchows Arch (Pathol Anat) 1981; 391:217-225
29. Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986; 103:313-318
30. Fong TA, Shawver LK, Sun L, et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res 1999; 59:99-106
31. Tuder RM, Cool CD, Yeager M, et al. The pathobiology of pulmonary hypertension: endothelium. Clin Chest Med 2001; 22:405-418
32. Tuder RM, Chacon M, Alger L, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 2001; 195:367-374
33. Voelkel NF, Cool C, Taraceviene-Stewart L, et al. Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. Crit Care Med 2002; 30:8251-8256
34. Lisanti MP, Scherer PE, Vidugiriene J, et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 1994; 126:111-126
35. Liu J, Wang XB, Park DS, et al. Caveolin-1 expression enhances endothelial capillary tubule formation. J Biol Chem 2002; 277:10661-10668
36. Thyberg J, Roy J, Tran PK, et al. Expression of caveolae on the surface of rat arterial smooth muscle cells is dependent on the phenotypic state of the cells. Lab Invest 1997; 77:93-101
37. Thyberg J. Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes. J Histochem Cytochem 2002; 50:185-195
38. Roy S, Luetterforst R, Harding A, et al. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterolrich plasma membrane domains. Nature Cell Biology 1999; 1:98-105
39. Feron O, Belhassen L, Kobzik L, et al. Endothelial nitric oxide synthase targeting to caveolae: specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996; 271:22810-22814
40. Mason NA, Springall DR, Burke M, et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 1998; 185:313-318
41. Hoekstra KA, Godin DV, Kurtu J, et al. Heme oxygenase and antioxidant status in cultured aortic endothelial cells isolated from atherosclerosis- susceptible and -resistant Japanese quail. Mol Cell Biochem 2003; 252:253-262
42. Bowers R, Cool C, Murphy RC, et al. Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 2004; 169:1-6
43. Burgermeister E, Tencer L, Liscovitch M. Peroxisome proliferator- activated receptor-γ upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells. Oncogene 2003; 22:3888-3900
44. Labrecque L, Royal I, Surprenant DS, et al. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell 2003; 14334-347
45. Park DS, Cohen AW, Frank PG, et al. Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry 2003; 42:15124-15131
46. Minshall RD, Sessa WC, Stan RV, et al. Caveolin regulation of endothelial function. Am J Physiol Lung Cell Mol Physiol 2003; 285:L1179-L1183
47. Ameshima S, Golpon H, Cool CD, et al. Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 2003; 92:1162-1169
48. Thyberg J. Caveolin-1 and caveolae act as regulators of mitogenic signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23:1481-1483
49. Peterson TE, Guicciardi ME, Gulati R, et al. Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 2003; 23:1521-1527
50. Gargalovic P, Dory L. Cellular apoptosis is associated with increased caveolin-1 expression in macrophages. J Lipid Res 2003; 44:1622-1632